Teva Recalls Over 500,000 Blood Pressure Pill Bottles Over Cancer Risk Fears

Teva Pharmaceuticals has issued a major nationwide recall. The action involves its Prazosin Hydrochloride capsules, a medication used to treat high blood pressure. This recall was initiated due to the detection of a potentially cancer-causing impurity.According to the U.S. Food and Drug Administration (FDA), the recall is classified as Class II. This means exposure to the recalled product could cause temporary or medically reversible health issues. The probability of serious harm, however, is low.

Details of the Contamination and Affected Products

The recall covers 580,844 bottles distributed across the United States. Testing revealed elevated levels of an impurity known as N-nitroso Prazosin impurity C. This substance is a nitrosamine, a class of chemicals linked to an increased cancer risk with long-term exposure.The affected products are Prazosin Hydrochloride Capsules USP in 1 mg, 2 mg, and 5 mg strengths. A total of 55 separate lots are involved in this voluntary action. The company has not received any reports of patient injuries linked to the impurity to date.

What Patients Need to Do Now

Patients currently taking this medication should not stop their treatment abruptly. Suddenly discontinuing blood pressure medicine can be dangerous. The first step is to check the bottle’s label for the lot number and contact your pharmacy.Pharmacists can verify if a specific bottle is part of the recalled lots. Patients must consult their prescribing doctor or healthcare provider for guidance. A healthcare professional can recommend an alternative treatment to ensure blood pressure remains controlled.Teva has instructed its distributors and customers to return all affected products. The company stated to Reuters that it prioritizes patient safety. They are committed to resolving this quality issue promptly.

Broader Context of Pharmaceutical Recalls

This incident is part of a wider trend of recalls involving nitrosamine impurities. In recent years, several other common drugs, including some heart medications and diabetes treatments, have faced similar issues. Regulators and manufacturers are now conducting more rigorous testing for these contaminants.For consumers, these recalls highlight the importance of robust quality control systems. They also show the effectiveness of post-market surveillance in catching potential problems. The system is designed to protect public health even after a product is widely distributed.

Wordle Hints Today: Answer for November 1, 2025

Patients are urged to check their medicine cabinets and contact their pharmacists immediately if they suspect they have a recalled product. This proactive step is crucial for managing potential health risks associated with the contaminated Prazosin capsules.

Info at your fingertips

What is Prazosin used for?

Prazosin is primarily prescribed to treat high blood pressure, or hypertension. It works by relaxing blood vessels to allow blood to flow more easily. It is also sometimes used off-label to manage nightmares associated with PTSD.

What should I do if I have the recalled pills?

First, contact your pharmacy to confirm your medication’s lot number is part of the recall. Do not stop taking your medicine without first talking to your doctor, as this could be risky. Your doctor can prescribe a safe alternative to manage your condition.

What is a Class II recall?

A Class II recall means a product might cause temporary or medically reversible health problems. The chance of serious injury is considered remote. This classification is used for situations that are not immediately life-threatening.

Has anyone gotten sick from this recall?

As of the latest reports, Teva has not received any complaints of injuries or adverse events related to this specific impurity. The recall is a precautionary measure based on laboratory testing that detected the impurity above acceptable levels.

Why do these impurity issues keep happening?

Nitrosamine impurities can form during the manufacturing process or from the breakdown of certain chemicals. Global regulators have recently heightened their scrutiny and testing for these substances, leading to more frequent detections and recalls across the industry.